Alumend is part of the Avera Research and operates primarily as a preclinical research and development group. Alumend is built on the innovative chemical and medical research of Avera research scientists. With a product portfolio focused on tissue healing and repair, Alumend aims to develop creative solutions for existing underserved clinical markets. The Alumend name represents Avera’s commitment to advance healthcare through the research and development of promising new chemical platforms, emphasizing both the ‘luminous’ nature of the company’s patented core technology, as well as its unique ability to ‘mend’ tissue.